What are Analysts opinions on: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)


Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) will report its next earnings on May 2 – May 8 (Est.). The company reported the earnings of $-0.61/Share in the last quarter where the estimated EPS by analysts was $-0.6/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -1.7%.

Many analysts are providing their Estimated Earnings analysis for Tetraphase Pharmaceuticals, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.62/share. These analysts have also projected a Low Estimate of $-0.65/share and a High Estimate of $-0.56/share.

Some buy side analysts are also providing their Analysis on Tetraphase Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 6 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 4 Analysts reported that the Price Target for Tetraphase Pharmaceuticals, Inc. might touch $14 high while the Average Price Target and Low price Target is $8.75 and $4 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Tetraphase Pharmaceuticals, Inc. got Downgrade on 13-May-16 where investment firm Gabelli & Co Downgrade the stock from Buy to Hold.

Tetraphase Pharmaceuticals, Inc. closed its last trading session at $6.95 with the gain of 11.8%. The Market Capitalization of the company stands at 311.89 Million. The Company has 52-week high of $7.85 and 52-week low of $3.11. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 37.97% where SMA50 and SMA200 are 63.88% and 85.48% respectively. The Company Touched its 52-Week High on Mar 13, 2017 and 52-Week Low on Nov 4, 2016.

The Relative Volume of the company is 3.82 and Average Volume (3 months) is 440.18 million. Tetraphase Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -43.5%. The Return on Equity (ROE) value stands at -46.4%. While it’s Return on Investment (ROI) value is -55.6%.

While looking at the Stock’s Performance, Tetraphase Pharmaceuticals, Inc. currently shows a Weekly Performance of 23.53%, where Monthly Performance is 75.4%, Quarterly performance is 67.82%, 6 Months performance is 105.01% and yearly performance percentage is 79.03%. Year to Date performance value (YTD perf) value is 92.8%. The Stock currently has a Weekly Volatility of 10.35% and Monthly Volatility of 7.64%.